Download PDFPDF

Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    • Josanne Aquilina, Consultant Neurologist
    • Other Contributors:
      • Maria Mallia, Stefania Chetcuti Zammit

    We read with great interest the review by Dr Shahrizaila and Prof Yuki on Bickerstaff brainstem encephalitis (BBE) and Fisher syndrome (FS) (1) and would like to refer in particular to the section about recurrent illnesses. As stated, FS and BBE are typically monophasic and recurrent episodes are rare. Although recurrent episodes have been described in the literature, after a thorough literature search, only one clear do...

    Show More
    Conflict of Interest:
    None declared.